Patent ID: 9683996
Date: 2017-06-20
CPC Classifications: G01N

Claim:
1. A method for assessing recurrence of and treating glioblastoma multiforme (GBM) in a cancer patient having had GBM, said method comprising: a) obtaining a post-treatment blood sample from said patient; b) subjecting said post-treatment blood sample from said patient to an antibody based technique for quantitation of expression of a membrane-associated form of at least one NKG2D ligand on myeloid cells of the sample, wherein the at least one NKG2D ligand comprises ULBP1; c) diagnosing said patient with recurrence of said GBM when an elevated level of expression of the at least one NKG2D ligand in said post-treatment blood sample is detected as compared to a control blood sample; and d) administering one or both of chemotherapy and radiation to said patient diagnosed with recurrence of said GBM.